Related Experiment Video
Updated: Jan 6, 2026

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
Published on: October 17, 2025
Anaplasma phagocytophilum Ats-1 is imported into host cell mitochondria and interferes with apoptosis induction
Hua Niu1, Vera Kozjak-Pavlovic, Thomas Rudel
1Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, USA.
Abstract:
Anaplasma phagocytophilum, the causative agent of human granulocytic anaplasmosis, infects human neutrophils and inhibits mitochondria-mediated apoptosis. Bacterial factors involved in this process are unknown. In the present study, we screened a genomic DNA library of A. phagocytophilum for effectors of the type IV secretion system by a bacterial two-hybrid system, using A. phagocytophilum VirD4 as bait. A hypothetical protein was identified as a putative effector, hereby named Anaplasmatranslocated substrate 1 (Ats-1). Using triple immunofluorescence labeling and Western blot analysis of infected cells, including human neutrophils, we determined that Ats-1 is abundantly expressed by A. phagocytophilum, translocated across the inclusion membrane, localized in the host cell mitochondria, and cleaved. Ectopically expressed Ats-1 targeted mitochondria in an N-terminal 17 residue-dependent manner, localized in matrix or at the inner membrane, and was cleaved as native protein, which required residues 55-57. In vitro-translated Ats-1 was imported in a receptor-dependent manner into isolated mitochondria. Ats-1 inhibited etoposide-induced cytochrome c release from mitochondria, PARP cleavage, and apoptosis in mammalian cells, as well as Bax-induced yeast apoptosis. Ats-1(55-57) had significantly reduced anti-apoptotic activity. Bax redistribution was inhibited in both etoposide-induced and Bax-induced apoptosis by Ats-1. Taken together, Ats-1 is the first example of a bacterial protein that traverses five membranes and prevents apoptosis at the mitochondria.
Insights
Anaplasma phagocytophilum uses a novel protein, Ats-1, to block host cell death by targeting mitochondria. This bacterial effector prevents apoptosis, offering new insights into infection mechanisms.
Area of Science:
- Microbiology
- Cell Biology
- Molecular Biology
Background:
- Anaplasma phagocytophilum causes human granulocytic anaplasmosis by infecting neutrophils.
- The bacterium inhibits host cell apoptosis, but the specific factors are unknown.
Purpose of the Study:
- To identify bacterial effectors involved in inhibiting host cell apoptosis.
- To characterize the function and localization of a novel effector, Anaplasma translocated substrate 1 (Ats-1).
Main Methods:
- Screening of an A. phagocytophilum genomic DNA library using a bacterial two-hybrid system.
- Triple immunofluorescence labeling, Western blot analysis, and ectopic expression studies.
- Mitochondrial import assays and apoptosis inhibition assays in mammalian cells and yeast.
Main Results:
- A hypothetical protein, Ats-1, was identified as a type IV secretion system effector.
- Ats-1 is translocated to and functions within host cell mitochondria, inhibiting apoptosis.
- Ats-1 specifically targets mitochondria via its N-terminus and prevents cytochrome c release and PARP cleavage.
Conclusions:
- Ats-1 is the first identified bacterial protein to translocate across five membranes to reach and inhibit host mitochondria.
- Ats-1 represents a novel mechanism by which bacteria subvert host cell death pathways to promote infection.
More Related Videos
10:42Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
Published on: June 17, 2022
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Published on: March 31, 2022
Related Concept Videos
08:58Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
10:42Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
07:07Synthetic Methodology for Asymmetric Ferrocene Derived Bio-conjugate Systems via Solid Phase Resin-based Methodology
16:30BioMEMS and Cellular Biology: Perspectives and Applications